{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Study+Powder&page=12", "query": { "intervention": "Study Powder", "page": 12 }, "page_size": 10 }, "pagination": { "page": 12, "page_size": 10, "total_count": 1207, "total_pages": 121, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Study+Powder&page=13&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Study+Powder&page=11&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-30T19:32:35.219Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00702325", "title": "Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Budesonide / formoterol fumarate (SYMBICORT)", "type": "DRUG" }, { "name": "Budesonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 311, "start_date": "2008-06", "completion_date": "2009-09", "has_results": true, "last_update_posted_date": "2012-11-09", "last_synced_at": "2026-10-30T19:32:35.219Z", "location_count": 57, "location_summary": "Pell City, Alabama • Bentonville, Arkansas • Hot Springs, Arkansas + 54 more", "locations": [ { "city": "Pell City", "state": "Alabama" }, { "city": "Bentonville", "state": "Arkansas" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Malvern", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00702325" }, { "nct_id": "NCT06382155", "title": "A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Idiopathic Short Stature" ], "interventions": [ { "name": "Vosoritide Injection", "type": "DRUG" }, { "name": "Human Growth Hormone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioMarin Pharmaceutical", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "3 Years to 11 Years" }, "enrollment_count": 100, "start_date": "2024-10-21", "completion_date": "2036-12", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-10-30T19:32:35.219Z", "location_count": 35, "location_summary": "California City, California • Los Angeles, California • Oakland, California + 28 more", "locations": [ { "city": "California City", "state": "California" }, { "city": "California City", "state": "California" }, { "city": "California City", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06382155" }, { "nct_id": "NCT02045797", "title": "Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Infections, Bacterial" ], "interventions": [ { "name": "GSK2140944 Lyophile", "type": "DRUG" }, { "name": "GSK2140944 Capsules", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 126, "start_date": "2014-03-24", "completion_date": "2015-06-29", "has_results": true, "last_update_posted_date": "2017-11-17", "last_synced_at": "2026-10-30T19:32:35.219Z", "location_count": 30, "location_summary": "Phoenix, Arizona • Anaheim, California • Chula Vista, California + 25 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02045797" }, { "nct_id": "NCT04002310", "title": "A Study to Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Macular Degeneration" ], "interventions": [ { "name": "BI 754132", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 18, "start_date": "2019-07-26", "completion_date": "2022-08-09", "has_results": true, "last_update_posted_date": "2023-09-15", "last_synced_at": "2026-10-30T19:32:35.219Z", "location_count": 8, "location_summary": "Beverly Hills, California • Pensacola, Florida • Winter Haven, Florida + 5 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Pensacola", "state": "Florida" }, { "city": "Winter Haven", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Asheville", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04002310" }, { "nct_id": "NCT01472757", "title": "Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "VR506", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vectura Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "12 Years to 65 Years" }, "enrollment_count": 374, "start_date": "2011-10", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2020-04-21", "last_synced_at": "2026-10-30T19:32:35.219Z", "location_count": 32, "location_summary": "Fountain Valley, California • Los Angeles, California • Mission Viejo, California + 28 more", "locations": [ { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Rancho Mirage", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01472757" }, { "nct_id": "NCT03643068", "title": "Phase 1A Study of the Safety of KSP/QRH Dimer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Adults" ], "interventions": [ { "name": "KSP-QRH-E3-IRDye800 (Peptide 919288G), 0.6 mg", "type": "DRUG" }, { "name": "KSP-QRH-E3-IRDye800 (Peptide 919288G), 1.8 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "25 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "25 Years to 100 Years" }, "enrollment_count": 26, "start_date": "2018-08-22", "completion_date": "2018-10-27", "has_results": false, "last_update_posted_date": "2018-11-06", "last_synced_at": "2026-10-30T19:32:35.219Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03643068" }, { "nct_id": "NCT01089127", "title": "Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Indacaterol", "type": "DRUG" }, { "name": "Salmeterol 50 μg", "type": "DRUG" }, { "name": "Placebo to indacaterol", "type": "DRUG" }, { "name": "Placebo to salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 552, "start_date": "2010-03", "completion_date": "2010-07", "has_results": true, "last_update_posted_date": "2011-08-19", "last_synced_at": "2026-10-30T19:32:35.219Z", "location_count": 69, "location_summary": "Florence, Alabama • Jasper, Alabama • Phoenix, Arizona + 63 more", "locations": [ { "city": "Florence", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Searcy", "state": "Arkansas" }, { "city": "Fullerton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01089127" }, { "nct_id": "NCT04129931", "title": "PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "MCT", "type": "DRUG" }, { "name": "Clazakizumab", "type": "DRUG" }, { "name": "Broncho-Vaxom", "type": "DRUG" }, { "name": "Imatinib Mesylate", "type": "DRUG" }, { "name": "Cavosonstat", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 950, "start_date": "2019-12-19", "completion_date": "2025-03-19", "has_results": true, "last_update_posted_date": "2026-04-01", "last_synced_at": "2026-10-30T19:32:35.219Z", "location_count": 29, "location_summary": "Scottsdale, Arizona • Tucson, Arizona • Sacramento, California + 17 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04129931" }, { "nct_id": "NCT02126839", "title": "A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol MDPI", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "ProAir HFA inhaler", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 186, "start_date": "2014-05", "completion_date": "2015-02", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-10-30T19:32:35.219Z", "location_count": 51, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Little Rock, Alaska + 45 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Little Rock", "state": "Alaska" }, { "city": "Anaheim", "state": "California" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02126839" }, { "nct_id": "NCT02067377", "title": "Efficacy of Serum Bovine Immunoglobulin in Improving Nutritional Status in Advanced COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Advanced COPD (GOLD Stage 3 or 4) With Cachexia" ], "interventions": [ { "name": "Serum bovine immunoglobulin (SBI) medical food", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo (for serum bovine immunoglobulin)", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Medical University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "30 Years to 80 Years" }, "enrollment_count": 12, "start_date": "2013-12", "completion_date": null, "has_results": false, "last_update_posted_date": "2016-09-02", "last_synced_at": "2026-10-30T19:32:35.219Z", "location_count": 1, "location_summary": "Charleston, South Carolina", "locations": [ { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02067377" } ] }